[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Azenta Inc (AZTA)

Azenta Inc (AZTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,041,241
  • Shares Outstanding, K 46,093
  • Annual Sales, $ 593,820 K
  • Annual Income, $ -55,760 K
  • EBIT $ -172 M
  • EBITDA $ -113 M
  • 60-Month Beta 1.39
  • Price/Sales 1.74
  • Price/Cash Flow 12.39
  • Price/Book 0.67

Options Overview Details

View History
  • Implied Volatility 59.45% (-19.62%)
  • Historical Volatility 99.08%
  • IV Percentile 23%
  • IV Rank 25.01%
  • IV High 116.51% on 03/11/26
  • IV Low 40.42% on 12/23/25
  • Expected Move (DTE 5) 0.00 (0.00%)
  • Put/Call Vol Ratio 0.31
  • Today's Volume 17
  • Volume Avg (30-Day) 773
  • Put/Call OI Ratio 1.84
  • Today's Open Interest 8,201
  • Open Int (30-Day) 6,489
  • Expected Range 22.59 to 22.59

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year $0.19
  • Growth Rate Est. (year over year) +525,689.47%

Price Performance

See More
Period Period Low Period High Performance
1-Month
15.93 +41.81%
on 05/18/26
24.36 -7.27%
on 06/03/26
+5.06 (+28.86%)
since 05/12/26
3-Month
15.93 +41.81%
on 05/18/26
27.68 -18.39%
on 04/21/26
+1.22 (+5.71%)
since 03/12/26
52-Week
15.93 +41.81%
on 05/18/26
41.73 -45.87%
on 01/22/26
-7.82 (-25.72%)
since 06/12/25

Most Recent Stories

More News
3 Hyped Up Stocks We Find Risky

3 Hyped Up Stocks We Find Risky

R : 280.33 (unch)
AZTA : 22.59 (+0.58%)
TKR : 137.06 (-0.25%)
3 Small-Cap Stocks with Open Questions

3 Small-Cap Stocks with Open Questions

AZTA : 22.59 (+0.58%)
KD : 11.70 (+3.72%)
ROG : 151.06 (+3.47%)
3 High-Flying Stocks Walking a Fine Line

3 High-Flying Stocks Walking a Fine Line

LASR : 69.66 (-0.76%)
AZTA : 22.59 (+0.58%)
AORT : 20.10 (-2.43%)
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Azenta, Inc. - AZTA

NEW YORK , June 4, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Azenta, Inc. ("Azenta" or the "Company") (NASDAQ: AZTA).  Such investors are advised to contact...

AZTA : 22.59 (+0.58%)
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Azenta, Inc. - AZTA

NEW YORK , May 28, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Azenta, Inc. ("Azenta" or the "Company") (NASDAQ: AZTA). Such investors are advised to contact...

AZTA : 22.59 (+0.58%)
Azenta, Inc. (AZTA) Securities Fraud Investigation - Levi & Korsinsky

Azenta, Inc. reaffirmed 3%-5% organic revenue growth and 300 basis points of margin expansion in February 2026 -- then cut both targets three months later after recording a $149 million goodwill impairment....

AZTA : 22.59 (+0.58%)
Investors in Azenta, Inc. (AZTA) Warned of Potential Securities Fraud - Contact Levi & Korsinsky Today

New York, New York--(Newsfile Corp. - May 25, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Azenta, Inc. (NASDAQ: AZTA) ("Azenta, Inc.") concerning potential violations...

AZTA : 22.59 (+0.58%)
Azenta, Inc. (AZTA) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

Law Offices of Howard G. Smith continues its investigation on behalf of Azenta, Inc. (“Azenta” or the “Company”) (NASDAQ: AZTA ) investors concerning the Company’s possible violations...

AZTA : 22.59 (+0.58%)
Securities Fraud Investigation Into Azenta, Inc. (AZTA) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

The Law Offices of Frank R. Cruz continues its investigation of Azenta, Inc. (“Azenta” or the “Company”) (NASDAQ: AZTA ) on behalf of investors concerning the Company’s...

AZTA : 22.59 (+0.58%)
Securities Fraud Investigation Into Azenta, Inc. (AZTA) Continues – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm

Glancy Prongay Wolke & Rotter LLP , a leading national shareholder rights law firm, continues its investigation on behalf of Azenta, Inc. (“Azenta” or the “Company”) (NASDAQ: AZTA...

AZTA : 22.59 (+0.58%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Sell with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Azenta Inc. is a provider of life sciences solutions. The company provides reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the pharmaceutical, biotech, academic and healthcare institutions. Azenta...

See More

Key Turning Points

3rd Resistance Point 23.77
2nd Resistance Point 23.45
1st Resistance Point 23.02
Last Price 22.59
1st Support Level 22.28
2nd Support Level 21.96
3rd Support Level 21.53

See More

52-Week High 41.73
Fibonacci 61.8% 31.87
Fibonacci 50% 28.83
Fibonacci 38.2% 25.79
Last Price 22.59
52-Week Low 15.93

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.